Previous studies on T2DM patients and T2DM mouse models have demonstrated poor glycemic control with significantly elevated levels of proinflammatory cytokines, including TNF-α, IL-6, and IL-1β (36, 37). The gene discussed is TNF; the disease is type 2 diabetes mellitus.